Pneumococcal vaccination in developing countries

Abstract

The authors urge donors and industry to negotiate sustainable affordable pricing of vaccines for developing countries, and the governments of developing countries and their partners to establish pneumococcal disease surveillance and begin preparations for vaccine introduction.

Citation

Lancet (2006) 367 (9526) 1880-1882 [doi:10.1016/S0140-6736(06)68703-5]

Pneumococcal vaccination in developing countries

Published 1 January 2006